An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

10.1002/pbc.26887

Saved in:

Bibliographic Details
Main Authors:	Dionne, Francois, Aminkeng, Folefac, Bhavsar, Amit P, Groeneweg, Gabriella, Smith, Anne, Visscher, Henk, Rassekh, Shahrad Rod, Ross, Colin, Carleton, Bruce
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Hematology Pediatrics anthracyclines cardiotoxicity dexrazoxane pharmacogenomics testing HEART-FAILURE DOXORUBICIN CARDIOTOXICITY CHILDREN DEXRAZOXANE PREVENTION MORTALITY SURVIVORS THERAPY LEUKEMIA SARCOMA
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235044
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer
by: Aminkeng, Folefac, et al.
Published: (2022)

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
by: Aminkeng, Folefac, et al.
Published: (2022)

Cardiotoxicity After Anthracycline Chemotherapy for Childhood Cancer in a Multiethnic Asian Population
by: Tan, VZZ, et al.
Published: (2021)

NA+/K+ ATPASE: A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF DOXORUBICIN-INDUCED CARDIOTOXICITY
by: LENG BIN
Published: (2024)

The emerging era of pharmacogenomics: current successes, future potential, and challenges
by: Lee, JW, et al.
Published: (2022)

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
by: Aminkeng, Folefac, et al.
Published: (2022)

Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice
by: Chua, C.C., et al.
Published: (2011)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Cheah, Irwin K, et al.
Published: (2023)

Investigation of the pathogenesis caused by exposure to varying doses of VX nerve agent in rat with special reference to cardiotoxicity
by: FONG XIAO JUN
Published: (2010)

Molecular basis of cardiotoxicity upon cobra envenomation
by: Cher, C.D.N., et al.
Published: (2012)

Multifactorial Prediction of Anthracycline-Induced Cardiotoxicity in Childhood Cancer: 10 Years of Active Surveillance and Pharmacogenomics Studies at the Canadian Pharmacogenomics Network for Drug Safety
by: Aminkeng, Folefac, et al.
Published: (2022)

Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy
by: Chan, A., et al.
Published: (2014)

Complete amino acid sequence of an acidic, cardiotoxic phospholipase A2 from the venom of Ophiophagus hannah (King cobra): A novel cobra venom enzyme with 'pancreatic loop'
by: Huang, M.Z., et al.
Published: (2014)

Complete amino acid sequence of an acidic, cardiotoxic phospholipase A2from the venom of Ophiophagus hannah (King cobra): A novel cobra venom enzyme with 'pancreatic loop'
by: Huang, M.Z., et al.
Published: (2012)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
by: Maillet, A, et al.
Published: (2020)

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
by: Chan, D., et al.
Published: (2014)

APPROACHES TO PHARMACOGENOMICS TRANSLATION IN PUBLIC HEALTH
by: TAN-KOI WEI CHUEN
Published: (2017)

Predicting Anthracycline-induced Cardiotoxicity in Children - Genome-Wide Association Study
by: Aminkeng, Folefac, et al.
Published: (2022)

SCALABLE TOPOGRAPHY-INDUCED CELL ALIGNMENT FOR TISSUE ENGINEERING APPLICATIONS
by: CHUKWUEMEKA GEORGE ONYEKA ANENE-NZELU
Published: (2014)

Singapore pharmacogenomics portal: A web resource for evaluating human genetic variations of genes responsible for drug responses
by: Wong, L.-P., et al.
Published: (2014)

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
by: Wright, Galen EB, et al.
Published: (2022)

RRM1 and RRM2 pharmacogenetics: Association with phenotypes in HapMap cell lines and acute myeloid leukemia patients
by: Cao, X., et al.
Published: (2016)

Data case Allopurinol Allergy
by: Hardyanto Soebono, Hardyanto
Published: (2022)

Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice
by: Adesta, Fadhli, et al.
Published: (2022)

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients
by: Lee, Joanne Shu Xian, et al.
Published: (2022)

Translational aspects of genetic factors in the prediction of drug response variability: A case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia
by: Chan, S.L., et al.
Published: (2014)

Zebrafish for drug toxicity screening: Bridging the in vitro cell-based models and in vivo mammalian models
by: Sukardi, H., et al.
Published: (2014)

P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells
by: Tay, Z., et al.
Published: (2014)

Pharmacogenomic diversity in Singaporean populations and Europeans
by: Brunham, LR, et al.
Published: (2022)

Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled Trial
by: Chung, R, et al.
Published: (2020)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
by: Lehnert, M., et al.
Published: (2014)

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
by: Lehnert, M., et al.
Published: (2016)

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
by: Khoury, Joseph D, et al.
Published: (2022)

Drug ADME-associated protein database as a resource for facilitating pharmacogenomics research
by: Zheng, C.J., et al.
Published: (2014)

Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation-an uncommon presentation in adults
by: Krishnan, S., et al.
Published: (2016)

Genome wide study of tardive dyskinesia in schizophrenia
by: Lim, Keane, et al.
Published: (2022)

Hemoglobin Constant Spring (Hb CS) Missed by HPLC in an Hb E Trait Pregnancy Resulting in Hb H-CS Disease in a Thai Girl: Utility of Capillary Electrophoresis
by: Pornprasert,S., et al.
Published: (2015)

Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand
by: Chong,H., et al.
Published: (2015)

A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease
by: Lithanatudom,P., et al.
Published: (2015)

Acquired hemophilia A in the HIV-infected patient: A case report and literature review
by: Rattanathammethee,T., et al.
Published: (2015)